SHR-2010 / Jiangsu Hengrui Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SHR-2010 / Jiangsu Hengrui Pharma
NCT05847920: Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Recruiting
2
76
RoW
SHR-2010 Injection, Placebo
Guangdong Hengrui Pharmaceutical Co., Ltd
Primary IgA Nephropathy
01/26
04/26

Download Options